INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
AJ
Corporate insider

Aryeh Jason

DirectorCIK 0001376960

EDGAR filingsOpen in network
Disclosed transactions7
Buys / sells0 / 3
Max Insider Score41
Connections with evidence1

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
25
AJ
Aryeh JasonDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale
SELL$90K
282 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    LIGAND PHARMACEUTICALS INCDirector · Dec 8, 2025
15
AJ
Aryeh JasonDirector
LGNDLIGAND PHARMACEUTICALS INC
Grant or award
A
—
2,938 sh
Jun 5, 2026
Jun 12, 2026
traded Jun 5, 2026
+7d
SEC FORM 4

Evidence

15
AJ
Aryeh JasonDirector
LGNDLIGAND PHARMACEUTICALS INC
Grant or award
A—
836 sh
Jun 5, 2026Jun 12, 2026
traded Jun 5, 2026
+7dSEC FORM 4

Evidence

41
AJ
Aryeh JasonDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale
SELL$1.13M
4,500 sh
Jun 11, 2026Jun 12, 2026
traded Jun 11, 2026
+1dSEC FORM 4

Evidence

39
AJ
Aryeh JasonDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale
SELL$125K
500 sh
Jun 10, 2026Jun 12, 2026
traded Jun 10, 2026
+2dSEC FORM 4

Evidence

12
AJ
Aryeh JasonDirector
LGNDLIGAND PHARMACEUTICALS INC
Option exercise
M$141K
2,034 sh
Dec 8, 2025Dec 8, 2025
traded Dec 8, 2025
+0dSEC FORM 4

Evidence

9
AJ
Aryeh JasonDirector
LGNDLIGAND PHARMACEUTICALS INC
Option exercise
M—
2,034 sh
Dec 8, 2025Dec 8, 2025
traded Dec 8, 2025
+0dSEC FORM 4

Evidence